ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
218.81
+0.24 (0.11%)
May 20, 2024, 3:59 PM EDT - Market closed
ResMed Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for ResMed stock have an average target of 212.3, with a low estimate of 169 and a high estimate of 260. The average target predicts a decrease of -2.98% from the current stock price of 218.81.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $205 → $200 | Buy | Maintains | $205 → $200 | -8.60% | Apr 26, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $187 → $200 | Hold | Maintains | $187 → $200 | -8.60% | Apr 26, 2024 |
| Keybanc | Keybanc | Buy Maintains $227 → $238 | Buy | Maintains | $227 → $238 | +8.77% | Apr 26, 2024 |
| Needham | Needham | Strong Buy Maintains $224 → $236 | Strong Buy | Maintains | $224 → $236 | +7.86% | Apr 26, 2024 |
| Needham | Needham | Strong Buy Maintains $215 → $224 | Strong Buy | Maintains | $215 → $224 | +2.37% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
4.68B
from 4.22B
Increased by 10.82%
Revenue Next Year
4.97B
from 4.68B
Increased by 6.22%
EPS This Year
7.48
from 6.09
Increased by 22.83%
EPS Next Year
8.21
from 7.48
Increased by 9.79%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.9B | 5.3B | 5.8B | 6.5B | 7.1B |
| Avg | 4.7B | 5.0B | 5.3B | 5.9B | 6.4B |
| Low | 4.5B | 4.3B | 4.3B | 5.4B | 6.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.8% | 13.3% | 16.8% | 22.1% | 20.7% |
| Avg | 10.8% | 6.2% | 6.4% | 10.7% | 9.1% |
| Low | 6.6% | -7.4% | -13.1% | 2.6% | 2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.09 | 9.43 | 10.40 | 11.70 | 13.04 |
| Avg | 7.48 | 8.21 | 8.98 | 10.38 | 11.57 |
| Low | 7.09 | 7.18 | 7.37 | 9.60 | 10.29 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 32.8% | 26.0% | 26.6% | 30.2% | 25.6% |
| Avg | 22.8% | 9.8% | 9.4% | 15.6% | 11.5% |
| Low | 16.5% | -4.0% | -10.3% | 6.9% | -0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.